XML 59 R15.htm IDEA: XBRL DOCUMENT v2.4.1.9
Note 7 - Investments in Marketable Securities
3 Months Ended
Mar. 31, 2015
Investments, Debt and Equity Securities [Abstract]  
Investments in Debt and Marketable Equity Securities (and Certain Trading Assets) Disclosure [Text Block]

Note 7 Investments in Marketable Securities


Our investments in marketable securities are classified as available for sale securities. Realized gains and losses from securities sales are recognized in results of operations upon disposition of the securities using the specific identification method on a trade date basis. Refer to Note 8 for a description of the Company's methodology for determining the fair value of marketable securities.


Marketable securities and restricted marketable securities consist of the following:


   

March 31, 2015

   

December 31, 2014

 

(in thousands)

 

Amortized

Cost

   

Fair

Value

   

Amortized

Cost

   

Fair

Value

 

Investments available for sale:

                               

Marketable equity securities

  $ 30,176     $ 134,795     $ 30,176     $ 132,535  

Restricted investments available for sale:

                         

Corporate debt securities

    65,803       66,887       68,594       68,916  

Commercial mortgage–backed securities

    59,353       59,711       63,351       63,252  

U.S. Treasury securities

    15,860       16,070       14,623       14,728  

State and municipal securities

    9,977       10,341       11,074       11,377  
    $ 181,169     $ 287,804     $ 187,818     $ 290,808  

Included in the available for sale marketable equity securities are the following (in thousands, except share amounts):


   

March 31, 2015

   

December 31, 2014

 
   

Shares

   

Cost

   

Fair

Value

   

Shares

   

Cost

   

Fair

Value

 

NHI Common Stock

    1,630,642     $ 24,734     $ 115,792       1,630,642     $ 24,734     $ 114,080  

The amortized cost and estimated fair value of debt securities classified as available for sale, by contractual maturity, are as follows:


   

March 31, 2015

   

December 31, 2014

 

(in thousands)

 

Cost

   

Fair Value

   

Cost

   

Fair

Value

 

Maturities:

                               

Within 1 year

  $ 12,306     $ 12,391     $ 11,161     $ 11,190  

1 to 5 years

    82,130       83,104       83,542       84,028  

6 to 10 years

    56,557       57,514       58,863       58,872  

Over 10 years

    -       -       4,076       4,183  
    $ 150,993     $ 153,009     $ 157,642     $ 158,273  

Gross unrealized gains related to available for sale securities are $106,864,000 and $103,814,000 as of March 31, 2015 and December 31, 2014, respectively. Gross unrealized losses related to available for sale securities are $229,000 and $824,000 as of March 31, 2015 and December 31, 2014, respectively. For the marketable securities in gross unrealized loss positions, (a) it is more likely than not that the Company will not be required to sell the investment securities before recovery of the unrealized losses, and (b) the Company expects that the contractual principal and interest will be received on the investment securities. As a result, the Company recognized no other-than-temporary impairment during the three months ended March 31, 2015 or the year ended December 31, 2014.


Proceeds from the sale of investments in restricted marketable securities during the three months ended March 31, 2015 and 2014 were $15,408,000 and $24,453,000, respectively. Investment gains of $341,000 and $136,000 were realized on these sales during the three months ended March 31, 2015 and 2014, respectively.